Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes mucocutaneous manifestations, including maculopapular eruptions, urticaria, and unusual acral vasculopathic rashes (pseudochilblains, pernio-like lesions) referred to as COVID toe. Cutaneous manifestations can occur in asymptomatic individuals, sometimes preceding COVID-19 symptoms, concurrent with COVID-19, or commonly after other COVID-19 symptoms (Freeman et al., 2020a; Seirafianpour et al., 2020). In a case series of 505 patients, 55% of the patients' only symptoms were pernio-like lesions lasting a median of 14 days (Freeman et al., 2020b).
